FDA Inspection 825335 — CorePharma, LLC

CorePharma, LLC — FEI 3002535019

The FDA completed an inspection of CorePharma, LLC on March 26, 2013 in Middlesex, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 26, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Middlesex, NJ (United States)